Corporate Governance

Corporate Profile

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges.

Shareholder Information
Exchange
NASDAQ Global Market (.O)
Stock Quote (CPHD)
13.37 
As of November 20, 2009 4:00 PM
Minimum 20 minutes delayed
Listed Security
CPHD Common Stock
Transfer Agent
Computershare Investor Services L.L.C.
2 North La Salle Street - 3rd Floor
Chicago, IL 60602 
Phone 866-222-5603
E-mail inquiry@computershare.com
Corporate Counsel
Fenwick & West, LLP
Independent Accountants
Ernst & Young LLP
303 Almaden Boulevard
San Jose, CA 95110 
URL http://www.ey.com

Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. All quotes are in local exchange time.
Intraday data provided by Comstock, a division of Interactive Data Corp. and subject to terms of use.

Historical, current end-of-day data, and splits data provided by FT Interactive Data.

Top Copyright © 2001, Cepheid